Mergers and Acquisitions Acquisitions


  • FRANKFURT, May 25- Bayer could receive financing from the European Central Bank that would help to fund a takeover of Monsanto, according to the terms of the ECB's bond-buying programme. U.S.-based Monsanto, the world's largest seed company, turned down Bayer's $62 billion bid on Tuesday, but said it was open to further negotiations. The ECB is buying 80 billion...

  • LONDON, May 25- Lawyers advising Dominic Chappell knew he had previously been declared bankrupt before he led the acquisition of the BHS department store chain from retail tycoon Philip Green, British lawmakers were told on Wednesday. However, as Chappell was a discharged bankrupt, meaning he had been set free of bankruptcy by the courts, this was no impediment...

  • NEW YORK— French drug company Sanofi is trying to toss the entire board at Medivation after the U.S. drugmaker rejected its $9.3 billion takeover bid. Sanofi said Medivation has refused to discuss a deal. Sanofi asked Medivation shareholders to approve its picks.

  • Monsanto worth $130 per share: Expert

    Dennis Gartman, founder, editor & publisher of The Gartman Letter, comments on Monsanto's decision to reject the Bayer acquisition proposal.

  • NEW YORK— Monsanto rejected Bayer's $62 billion takeover bid, calling it "incomplete and financially inadequate." Monsanto Co. Chairman and CEO Hugh Grant also said in a written statement that the initial offer failed to address potential financing and regulatory risks. Bayer AG, a German drug and chemicals company, made an all-cash bid that valued Monsanto's...

  • Hanging ten on wave technology

    Paul Speaker, World Surf League, talks about champion surfer Kelly Slater, and the growing popularity of digitized surfing.

  • Telecom network equipment maker Nokia may cut 10,000 to 15,000 jobs as part of a cost-cutting programme, a union representative said.

  • The value of M&A to pharma

    John Rountree, managing partner at Novasecta, talks about whether or not the Bayer-Monsanto merger would create more or less innovation and value.

  • Will the Bayer-Monsanto deal happen?

    Scott Moeller, director of the M&A Research Centre at Cass Business School, and John Rountree, from Novasecta, discuss the Bayer-Monsanto deal.

  • LONDON, May 23- U.S. investment firm General Atlantic will acquire a majority stake in oil price reporting agency Argus Media in a deal valuing London- based Argus at nearly 1 billion pounds. Argus, which competes with news and pricing agencies such as Platts and Thomson Reuters, hired Bank of America Merrill Lynch last year to review its strategic options after...

  • LONDON, May 23- U.S. investment firm General Atlantic will acquire a majority stake in oil price reporting agency Argus Media in a deal valuing London- based Argus at nearly 1 billion pounds. Under the deal, the Argus executive chairman, Adrian Binks, will continue in the business and retain the "majority of his significant shareholding in the new structure...

  • NEW YORK— Tribune Publishing rejected a second takeover bid from USA Today owner Gannett, but did say Monday that it was open to further talks. Gannett last week raised its per-share bid for the owner of the Los Angeles Times, Chicago Tribune and other newspapers to $15, from $12.25. Gannett Co. said Monday that it will determine whether to continue its pursuit of...

  • Monsanto deal stands on its own merits: Bayer CEO

    Werner Baumann, Bayer CEO, weighs in on the tax ramification of the combined companies.

  • Haven't heard from Monsanto yet: Bayer CEO

    Werner Baumann, Bayer CEO, explain why he went public with the $62 billion bid for Monsanto.

  • *Proposes $122 per share in cash, 37 pct premium. FRANKFURT, May 23- German drugs and crop chemicals group Bayer has offered to buy U.S. seeds company Monsanto for $62 billion in cash, including debt, which would be the biggest foreign takeover by a German firm if the unsolicited proposal is accepted. The offer of $122 per share represents a 37 percent premium to...

  • Bayer bids $62B for Monsanto

    CNBC's Nancy Hulgrave reports on Bayer's big move to create a global leader in agriculture.

  • Is Bayer biting off more than it can chew with Monsanto?

    Julien Jarmoszko, senior research manager at S&P Global Market Intelligence, talks about Bayer's decision to acquire Monsanto.

  • Bayer and Monsanto 'compliment' each other: CEO

    Werner Baumann, Bayer CEO, explains why he thinks the company's offer for Monsanto would likely pass regulatory scrutiny and doesn't see risk in the deal.

  • FRANKFURT, Germany— Bayer wants to buy Monsanto for $62 billion, hooking up the German chemical and drug company with the St. Louis- based producer of seeds and weed-killers. A: Bayer is offering to acquire Monsanto, which makes seeds for fruits, vegetables, corn, soybeans and cotton, as well as weed-killer Roundup. That compares with a closing price Friday of $101.52...

  • Bayer offers $122 per share for Monsanto

    The pharmaceutical company Bayer has announced plans to acquire American biotech company Monsanto, making an all cash offer of $122 per share.